Skip Nav Destination
Issues
March 2009
ISSN 0030-2414
EISSN 1423-0232
In this Issue
Journal Name Change
Vol. 1-20 (1948-1966) were published under the journal's former title Oncologia.
Oncology 2009, Vol. 76, No. 4
Editorial
Hypersensitivity Reactions: An Increasingly Recognized Toxicity of Platinum Agents
Subject Area:
Oncology
Oncology (2009) 76 (4): 229–230.
https://doi.org/10.1159/000205262
Clinical Study
Hypersensitivity to Oxaliplatin: An Investigation of Incidence and Risk Factors, and Literature Review
Subject Area:
Oncology
Oncology (2009) 76 (4): 231–238.
https://doi.org/10.1159/000205263
Comparison of Survival in Advanced Non-Small Cell Lung Cancer Patients in the Pre- and Post-Gefitinib Eras
Subject Area:
Oncology
Hyo Song Kim; Keunchil Park; Hyun Jung Jun; Seong Yoon Yi; Jeeyun Lee; Jin Seok Ahn; Yeon Hee Park; Seonwoo Kim; Sangcheol Lee; Myung-Ju Ahn
Oncology (2009) 76 (4): 239–246.
https://doi.org/10.1159/000205386
Systemic Therapy of Metastatic Breast Cancer: The Truth Beyond the Clinical Trials
Subject Area:
Oncology
Oncology (2009) 76 (4): 247–253.
https://doi.org/10.1159/000205387
Capecitabine and Celecoxib as Second-Line Treatment of Advanced Pancreatic and Biliary Tract Cancers
Subject Area:
Oncology
Maria S. Pino; Michele Milella; Alain Gelibter; Isabella Sperduti; Salvatore De Marco; Carmen Nuzzo; Emilio Bria; Livio Carpanese; Enzo M. Ruggeri; Paolo Carlini; Francesco Cognetti
Oncology (2009) 76 (4): 254–261.
https://doi.org/10.1159/000205388
Clinical and Biological Prognostic Factors in 179 Cases with Sinonasal Carcinoma Treated in the Italian Piedmont Region
Subject Area:
Oncology
Mario Airoldi; Massimiliano Garzaro; Guido Valente; Carlo Mamo; Antonella Bena; Carlo Giordano; Giancarlo Pecorari; Pietro Gabriele; Anna Maria Gabriele; Fabio Beatrice
Oncology (2009) 76 (4): 262–269.
https://doi.org/10.1159/000206140
Phase II Study of Docetaxel and Gefitinib as Second-Line Therapy in Gemcitabine Pretreated Patients with Advanced Pancreatic Cancer
Subject Area:
Oncology
Joanna M. Brell; Khalid Matin; Terry Evans; Robert L. Volkin; Gauri J. Kiefer; James J. Schlesselman; Shelley Dranko; Linda Rath; Amy Schmotzer; Diana Lenzner; Ramesh K. Ramanathan
Oncology (2009) 76 (4): 270–274.
https://doi.org/10.1159/000206141
Trastuzumab Combined with Pegylated Liposomal Doxorubicin in Patients with Metastatic Breast Cancer: Phase II Study of the Hellenic Cooperative Oncology Group (HeCOG) with Biomarker Evaluation
Subject Area:
Oncology
Christos Christodoulou; Ioannis Kostopoulos; Haralabos P. Kalofonos; Evangelos Lianos; Mattheos Bobos; Evangelos Briasoulis; Helen Gogas; Evangelia Razis; Dimosthenis V. Skarlos; George Fountzilas
Oncology (2009) 76 (4): 275–285.
https://doi.org/10.1159/000207504
The Relationship between the Glucose Transporter Type 1 Expression and 18F-Fluorodeoxyglucose Uptake in Esophageal Squamous Cell Carcinoma
Subject Area:
Oncology
Yukiharu Hiyoshi; Masayuki Watanabe; Yu Imamura; Youhei Nagai; Yoshifumi Baba; Naoya Yoshida; Eiichiro Toyama; Naoko Hayashi; Hideo Baba
Oncology (2009) 76 (4): 286–292.
https://doi.org/10.1159/000207505
Clinical Translational Research
A Comprehensive Analysis of Immunohistochemical Studies in Intrahepatic Cholangiocarcinoma Using the Survival Tree Model
Subject Area:
Oncology
Tomohiro Iguchi; Natsumi Yamashita; Shinichi Aishima; Yousuke Kuroda; Takahiro Terashi; Keishi Sugimachi; Ken-ichi Taguchi; Akinobu Taketomi; Yoshihiko Maehara; Masazumi Tsuneyoshi
Oncology (2009) 76 (4): 293–300.
https://doi.org/10.1159/000207506
